Larimar Therapeutics Inc. (LRMR)

AI Score

Unlock

2.00

-0.20 (-9.09%)

At close: Apr 03, 2025, 2:17 PM

Larimar Therapeutics Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	311K	272K	326K	155K	78K	261K	188K	212K	70K	n/a	12K	11K	4K
Gross Profit	n/a	-311K	-272K	-326K	-155K	-78K	-261K	-188K	-212K	-70K	n/a	-12K	-11K	-4K
Operating Income	-90.89M	-41.76M	-36.53M	-50.47M	-42.8M	-23.21M	-62.72M	-53.88M	-57.12M	-73.81M	-35.53M	-13.78M	-13.79M	-13.15M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	996K	894K	438K	28K	n/a	n/a	n/a
Pretax Income	-80.6M	-36.95M	-35.35M	-50.64M	-42.48M	-23.13M	-62.97M	-52.93M	-58.18M	-74.29M	-36.57M	-14.03M	-13.88M	-13.16M
Net Income	-80.6M	-36.95M	-34.18M	-50.31M	-42.33M	-23.13M	-61.37M	-52.03M	-57.88M	-74.29M	-36.57M	-14.03M	-13.88M	-13.16M
Selling & General & Admin	17.61M	14.09M	12.28M	12.07M	11.4M	2.42M	12.93M	11.95M	17.14M	19.13M	8.14M	4.21M	2.24M	1.75M
Research & Development	73.28M	27.36M	24.25M	38.4M	31.41M	20.79M	49.53M	41.74M	39.77M	54.62M	27.39M	9.56M	11.54M	11.4M
Other Expenses	n/a	n/a	1.17M	-171K	322K	82K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	90.89M	41.76M	36.53M	50.47M	42.8M	23.21M	62.46M	53.69M	56.91M	73.74M	35.53M	13.77M	13.78M	13.15M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	971K	347K	806K	-870K	n/a	97K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	12.93M	-212K	-1.15M	-70K	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	41.76M	36.53M	50.47M	42.8M	23.21M	62.72M	53.88M	57.12M	73.81M	35.53M	13.78M	13.79M	13.15M
Income Tax Expense	n/a	n/a	-1.17M	-326K	-155K	-93.86K	-1.6M	-900K	-300K	-946K	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	61.26M	43.9M	25.76M	17.16M	11.88M	9.21M	2.69M	2.29M	2.27M	2.23M	2.42M	2.18M	2.18M	2.18M
Shares Outstanding (Diluted)	61.26M	43.9M	25.76M	17.16M	11.88M	9.21M	2.69M	2.29M	2.27M	2.23M	2.42M	2.18M	2.18M	2.18M
EPS (Basic)	-1.32	-0.84	-1.33	-2.93	-3.56	-2.51	-22.85	-22.76	-25.44	-33.32	-15.14	-6.54	-6.4	-6.07
EPS (Diluted)	-1.32	-0.84	-1.33	-2.93	-3.56	-2.51	-22.85	-22.76	-25.44	-33.32	-15.14	-6.54	-6.4	-6.07
EBITDA	-90.89M	-41.45M	-35.08M	-50.14M	-42.65M	-23.14M	-60.81M	-52.58M	-57.44M	-73.41M	-35.53M	-14.02M	-13.77M	-13.15M
EBIT	n/a	-41.76M	-36.53M	-50.64M	-42.8M	-23.21M	-61.07M	-52.76M	-57.65M	-73.48M	-35.61M	-14.03M	-13.78M	-13.16M
Depreciation & Amortization	n/a	311K	272K	326K	155K	78K	261K	188K	212K	70K	n/a	12K	11K	4K